Bora Pharmaceuticals Co., LTD. (TPEX:6472) agreed to acquire TWi Pharmaceuticals, Inc. on June 14, 2022. Consideration will be paid in the form of USD 1.7196 per share.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
800 TWD | +7.96% | +12.20% | +25.20% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.20% | 2.5B | |
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+13.91% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |
- Stock Market
- Equities
- 6472 Stock
- News Bora Pharmaceuticals Co., LTD.
- Bora Pharmaceuticals Co., LTD. agreed to acquire TWi Pharmaceuticals, Inc.